ROMPIETTI, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 306
NA - Nord America 277
AS - Asia 98
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 685
Nazione #
US - Stati Uniti d'America 276
IT - Italia 136
IE - Irlanda 101
HK - Hong Kong 52
VN - Vietnam 24
RO - Romania 21
CN - Cina 20
FI - Finlandia 14
UA - Ucraina 8
RU - Federazione Russa 7
SE - Svezia 5
DE - Germania 4
BE - Belgio 3
CI - Costa d'Avorio 3
CH - Svizzera 2
NL - Olanda 2
AT - Austria 1
CA - Canada 1
EU - Europa 1
FR - Francia 1
GR - Grecia 1
JP - Giappone 1
SG - Singapore 1
Totale 685
Città #
Dublin 101
Chandler 84
Perugia 66
Hong Kong 52
San Mateo 33
Dong Ket 24
Bucharest 21
Altamura 13
Beijing 13
New York 12
Helsinki 11
Wilmington 10
Medford 9
Princeton 9
Andover 8
Lawrence 8
Assisi 5
Falls Church 5
Bastia 4
Bologna 4
Collazzone 4
Dearborn 4
Rome 4
Abidjan 3
Brussels 3
Des Moines 3
Foligno 3
Los Angeles 3
Amsterdam 2
Ancona 2
Changsha 2
Moscow 2
Redwood City 2
Saint Petersburg 2
Ashburn 1
Boardman 1
Chengdu 1
Civitanova Marche 1
Guangzhou 1
Hanover 1
Hefei 1
Lappeenranta 1
Ludwigshafen 1
Montréal 1
Nanjing 1
Quattro Castella 1
Redmond 1
San Paolo di Civitate 1
Shenzhen 1
Tokyo 1
Vienna 1
Totale 548
Nome #
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 120
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 65
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 65
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 63
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 62
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 59
NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML 52
Blockade of Oncogenic NOTCH1 With the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 49
CURCUMIN EXHIBITS IN VITRO AND IN VIVO ANTI-LEUKEMIC ACTIVITY INTERFERING WITH THE NOTCH1 PATHWAY AND INDUCING ENDOPLASMIC RETICULUM STRESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 29
Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia 29
Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia 27
NOTCH-1 ACTIVATION AND SUBCLONAL MUTATION NEGATIVELY IMPACT ON CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOMES 26
A NOVEL MECHANISM FOR NOTCH1 ACTIVATIONIN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS: INVOLVEMENT OF NOTCH1 ENDOSOMAL TRAFFICKING AND ALTERATIONS IN RAB PROTEINS 23
GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL 19
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 19
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia 13
FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemia 7
NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential 6
Totale 733
Categoria #
all - tutte 3.488
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.488


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20196 0 0 0 0 0 0 0 0 0 0 6 0
2019/202042 0 0 0 1 0 4 0 5 4 26 2 0
2020/202168 2 6 0 1 18 2 0 3 3 1 8 24
2021/2022163 2 31 1 0 4 3 1 23 2 30 29 37
2022/2023290 9 39 1 27 30 20 11 21 116 0 11 5
2023/2024130 6 14 10 9 0 7 67 1 11 4 1 0
Totale 733